scholarly article | Q13442814 |
P356 | DOI | 10.1111/ACER.12581 |
P8608 | Fatcat ID | release_sdrtdn4b5jfa3d7kl4ughjn5hm |
P932 | PMC publication ID | 4293087 |
P698 | PubMed publication ID | 25581657 |
P5875 | ResearchGate publication ID | 270649832 |
P50 | author | Markus Heilig | Q42632514 |
P2093 | author name string | David T George | |
Primavera A Spagnolo | |||
Julie M Usala | |||
Melanie L Schwandt | |||
Reza Momenan | |||
Sara K Blaine | |||
Lishu Zhang | |||
Vijay A Ramchandani | |||
Kristie A Diamond | |||
Monte J Phillips | |||
P2860 | cites work | Subjective and neural responses to intravenous alcohol in young adults with light and heavy drinking patterns | Q22251050 |
Opioid antagonists for alcohol dependence | Q24244900 | ||
Associations among GABRG1, level of response to alcohol, and drinking behaviors | Q24622050 | ||
Why we like to drink: a functional magnetic resonance imaging study of the rewarding and anxiolytic effects of alcohol | Q24647841 | ||
AFNI: software for analysis and visualization of functional magnetic resonance neuroimages | Q29547544 | ||
Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats | Q29619737 | ||
Linking nucleus accumbens dopamine and blood oxygenation. | Q31097702 | ||
Neurochemical characteristics associated with ethanol preference in selected alcohol-preferring and -nonpreferring rats: a quantitative microdialysis study | Q32117651 | ||
A genetic determinant of the striatal dopamine response to alcohol in men | Q34077390 | ||
Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research | Q34091192 | ||
Decreased brain reward produced by ethanol withdrawal | Q34161433 | ||
Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms | Q36424583 | ||
Ethanol inhibition of m-current and ethanol-induced direct excitation of ventral tegmental area dopamine neurons | Q36637507 | ||
Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people | Q36824245 | ||
The μ opioid receptor is not involved in ethanol-stimulated dopamine release in the ventral striatum of C57BL/6J mice | Q36848918 | ||
Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway | Q36877274 | ||
Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics | Q37702325 | ||
Association of µ-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis | Q38003649 | ||
Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. | Q38407349 | ||
Exposure to negative emotional cues and alcohol cue reactivity with alcoholics: a preliminary investigation | Q40869793 | ||
Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence | Q40913413 | ||
Endogenous opioid systems and alcohol addiction | Q41353548 | ||
Plasma beta-endorphin, but not met-enkephalin levels are abnormal in chronic alcoholics | Q41989024 | ||
Ethanol consumption and reward are decreased in mu-opiate receptor knockout mice | Q43567780 | ||
Predicting treatment response to naltrexone: the influence of craving and family history | Q43752726 | ||
Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms. | Q44132559 | ||
mu-Opioid receptor knockout mice do not self-administer alcohol | Q44332073 | ||
Alcohol consumption induces endogenous opioid release in the human orbitofrontal cortex and nucleus accumbens. | Q44332464 | ||
A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans | Q44347594 | ||
Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil | Q44347678 | ||
A dopamine-mu1 opioid link in the rat ventral tegmentum shared by palatable food (Fonzies) and non-psychostimulant drugs of abuse. | Q44350045 | ||
Plasticity of reward neurocircuitry and the 'dark side' of drug addiction | Q46177203 | ||
Mesolimbic functional magnetic resonance imaging activations during reward anticipation correlate with reward-related ventral striatal dopamine release | Q46182958 | ||
Clinical predictors of response to naltrexone in alcoholic patients: who benefits most from treatment with naltrexone? | Q46410737 | ||
Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats | Q46694717 | ||
Differences in the peripheral levels of beta-endorphin in response to alcohol and stress as a function of alcohol dependence and family history of alcoholism | Q46844751 | ||
Suppression of ethanol-reinforced behavior by naltrexone is associated with attenuation of the ethanol-induced increase in dialysate dopamine levels in the nucleus accumbens. | Q48329536 | ||
Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area | Q48435230 | ||
Repeated ethanol administration induces short- and long-term changes in enkephalin and dynorphin tissue concentrations in rat brain | Q48691034 | ||
Alcohol cue reactivity: effects of detoxification and extended exposure. | Q48813258 | ||
Decreases in dopamine receptors but not in dopamine transporters in alcoholics | Q48846413 | ||
Predictors of compliance with naltrexone among alcoholics. | Q51074316 | ||
Effects of naltrexone on cue-elicited craving for alcohol and cocaine. | Q51099160 | ||
Ethanol self-administration in males with and without an alcoholic first-degree relative. | Q51170071 | ||
Genetic moderators of naltrexone's effects on alcohol cue reactivity. | Q51791744 | ||
Naltrexone's effect on cue-elicited craving among alcoholics in treatment. | Q52174765 | ||
Immunoreactive met-enkephalin plasma concentrations in chronic alcoholics and in children born from alcoholic mothers. | Q52270436 | ||
Psychometric properties of the Penn Alcohol Craving Scale. | Q52277465 | ||
The reliability of a timeline method for assessing normal drinker college students' recent drinking history: utility for alcohol research | Q69582841 | ||
Alcohol dependence syndrome: measurement and validation | Q70404143 | ||
The effects of 6-hydroxydopamine lesions of the nucleus accumbens and the mesolimbic dopamine system on oral self-administration of ethanol in the rat | Q72558093 | ||
Naltrexone in the treatment of alcohol dependence | Q77347366 | ||
P433 | issue | 12 | |
P921 | main subject | naltrexone | Q409587 |
P304 | page(s) | 3024-3032 | |
P577 | publication date | 2014-12-01 | |
P1433 | published in | Alcoholism: Clinical and Experimental Research | Q4713331 |
P1476 | title | Effects of naltrexone on neural and subjective response to alcohol in treatment-seeking alcohol-dependent patients | |
P478 | volume | 38 |
Q58702818 | A preliminary randomized clinical trial of naltrexone reduces striatal resting state functional connectivity in people with methamphetamine use disorder |
Q56232885 | Brain Functional Magnetic Resonance Imaging Cue-reactivity Can Predict Baclofen Response in Alcohol Use Disorders |
Q44339317 | Low μ-Opioid Receptor Status in Alcohol Dependence Identified by Combined Positron Emission Tomography and Post-Mortem Brain Analysis. |
Q92219312 | Naltrexone Acutely Enhances Connectivity Between the Ventromedial Prefrontal Cortex and a Left Frontoparietal Network |
Q47413666 | Reductions in Alcohol Craving Following Naltrexone Treatment for Heavy Drinking |
Q38848288 | The Need for Treatment Responsive Translational Biomarkers in Alcoholism Research |
Q89707176 | To Infuse or Ingest in Human Laboratory Alcohol Research |
Search more.